Bausch Health Cos Return on Investment 2010-2024 | BHC

Current and historical return on investment (ROI) values for Bausch Health Cos (BHC) over the last 10 years.
Bausch Health Cos ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-09-30 $1.35B $20.81B 6.35%
2024-06-30 $1.05B $20.98B 4.87%
2024-03-31 $1.07B $21.36B 5.02%
2023-12-31 $0.96B $21.86B 4.57%
2023-09-30 $0.36B $21.66B 1.72%
2023-06-30 $0.59B $20.38B 2.84%
2023-03-31 $0.34B $20.35B 1.60%
2022-12-31 $0.45B $20.59B 2.09%
2022-09-30 $1.07B $21.24B 4.80%
2022-06-30 $1.40B $21.92B 6.21%
2022-03-31 $0.96B $23.03B 4.25%
2021-12-31 $0.45B $22.62B 1.97%
2021-09-30 $0.08B $22.22B 0.33%
2021-06-30 $-0.04B $22.83B -0.15%
2021-03-31 $0.21B $23.61B 0.84%
2020-12-31 $0.68B $24.53B 3.63%
2020-09-30 $-0.40B $25.00B -2.09%
2020-06-30 $-0.53B $24.90B -2.74%
2020-03-31 $-0.24B -1.23%
2019-12-31 $-0.20B $25.80B -0.77%
2019-09-30 $0.90B $26.03B 3.38%
2019-06-30 $0.69B $26.71B 2.54%
2019-03-31 $0.18B $26.70B 0.67%
2018-12-31 $-2.38B $26.89B -8.46%
2018-09-30 $-2.73B $27.67B -9.33%
2018-06-30 $-2.81B $28.42B -9.29%
2018-03-31 $-2.39B $29.79B -7.69%
2017-12-31 $0.10B $31.18B 0.32%
2017-09-30 $0.57B $31.64B 1.79%
2017-06-30 $-0.33B $31.68B -0.99%
2017-03-31 $-0.42B $32.19B -1.24%
2016-12-31 $-0.57B $33.10B -1.61%
2016-09-30 $-0.55B $34.66B -1.52%
2016-06-30 $0.76B $36.18B 2.08%
2016-03-31 $1.02B $37.08B 2.79%
2015-12-31 $1.53B $36.29B 4.30%
2015-09-30 $1.97B $36.64B 6.21%
2015-06-30 $2.20B $36.85B 7.95%
2015-03-31 $2.22B $32.47B 9.20%
2014-12-31 $2.00B $20.63B 9.28%
2014-09-30 $1.62B $20.82B 7.36%
2014-06-30 $0.04B $22.43B 0.20%
2014-03-31 $-0.17B $22.35B -0.82%
2013-12-31 $-0.41B $22.40B -2.20%
2013-09-30 $-0.73B $22.11B -4.41%
2013-06-30 $0.19B $16.15B 1.36%
2013-03-31 $0.14B $13.91B 1.07%
2012-12-31 $0.08B $14.25B 0.67%
2012-09-30 $0.17B $11.21B 1.57%
2012-06-30 $0.25B $11.05B 2.44%
2012-03-31 $0.29B $10.93B 2.86%
2011-12-31 $0.30B $10.47B 3.12%
2011-09-30 $0.26B $9.20B 2.83%
2011-06-30 $0.02B $9.20B 0.20%
2011-03-31 $-0.05B $9.41B -0.73%
2010-12-31 $-0.11B $8.39B -2.18%
2010-09-30 $-0.00B $8.46B -0.06%
2010-06-30 $0.18B $1.66B 14.58%
2010-03-31 $0.14B $1.66B 17.30%
2009-12-31 $0.18B $1.67B 43.65%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.597B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00